Biotin: Clinical Trials

1 trial of Biotin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Terminated 1

Follow Biotin: new trials by email Literature Review of Biotin trials Research Report on Biotin

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effect of MD1003 in Progressive Multiple Sclerosis (SPI2)
MD1003 100mg capsule, PLACEBO - Multiple Sclerosis
Phase 3TerminatedMedDay Pharmaceuticals SA6422016-12-012020-11-23

Conditions studied

Multiple Sclerosis (1)  ·  Multiple Sclerosis, Chronic Progressive (1)

Sponsors

MedDay Pharmaceuticals SA (1)

Countries

Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  Czechia (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Poland (1)  ·  Spain (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Bruce Cree, MD, PHD (1)  ·  Frederic Sedel, MD, PHD (1)

Results publications

PMID 33222767, PMID 42712237